Togo has observed a 4% (5.3%) increase in the pregnant women living with hiv antiretroviral therapy coverage for pmtct, which now stands at 79%.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Togo
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Togo
PMTCT antiretroviral therapy coverage
More indicators for Togo
Male unintentional poisoning
2.6
0.0
(2019)
Female wasting in children
5.3%
-0.3%
(2017)
Female prevalence of HIV
0.8%
0%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar90
+intl dollar5
(2021)
Birth registration
82.9%
+4.9%
(2017)
Contraceptive modern method prevalence
21.4%
+4.1%
(2017)
Togo PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 79% | +4% |
| 2021 | 75% | +2% |
| 2020 | 73% | -11% |
| 2019 | 84% | +1% |
| 2018 | 83% | +10% |
| 2017 | 73% | -16% |
| 2016 | 89% | +6% |
| 2015 | 83% | +6% |
| 2014 | 77% | +2% |
| 2013 | 75% | +4% |
| 2012 | 71% | +6% |
| 2011 | 65% | +34% |
| 2010 | 31% | +10% |
| 2009 | 21% | +5% |
| 2008 | 16% | +6% |
| 2007 | 10% | +2% |
| 2006 | 8% | +4% |
| 2005 | 4% | +2% |
| 2004 | 2% | +1% |
| 2003 | 1% | +1% |
| 2002 | 0% | 0% |
| 2001 | 0% | 0% |
| 2000 | 0% |